CONTENTS:
- Responding to medicinal and non-medicinal ketamine use [Editorial]. Bowden-Jones O., Sahai A., Dargan P., p. 1494-1496.
- Recovery support services as part of the continuum of care for alcohol or drug use disorders. Day E., Pechey L.C., Roscoe S., Kelly J.F., p. 1497-1520.
- Commentary on Day et al.: From concept to practice - Challenges in building a continuum of recovery support services in Belgium. Vanderplasschen W., De Meyer F., De Ruysscher C., p. 1521-1523.
- Commentary on Day et al.: Systemic solutions for recovery support services in Ireland's National Drug Strategy. Ivers J.H., p. 1524-1525.
- Commentary on Day et al.: Singapore's approach toward drug rehabilitation. Samion S., Kaur J., Leung C.C., p. 1526-1528.
- To determine whether the whole recovery-oriented system of care is greater than the sum of its parts, we must start by describing the parts. Day E., Roscoe S., Pechey L., Kelly J., p. 1529-1530.
- How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta-analysis. Kwan I., Burchett H.E.D., Macdowall W., D'Souza P., Stansfield C., Kneale D., et al., p. 1531-1550.
- A systematic review of adolescent alcohol-related harm trends in high-income countries with declines in adolescent consumption. Vieira E., Taylor N., Stevely A., Pennay A., Raninen J., Holmes J., et al., p. 1551-1570.
- Longitudinal patterns of e-cigarette use initiation and progression to frequent vaping from mid-to-late adolescence to young adulthood. Cho J., Harlow A.F., Leventhal A.M., Pentz M.A., Bae D., Han D.H., et al., p. 1571-1581.
- How much does the absence of the 'hidden population' from United Kingdom household surveys underestimate smoking prevalence? Beard E., Shahab L., Brown J., Cox S., p. 1582-1600.
- Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study. Santo T.J., Jr., Chaillon A., Martin N., Hickman M., Jones N., Farrell M., et al., p. 1601-1609.
- Medication experiences in the treatment of opioid use disorders: Insights from Reddit. Almeida A., Conway M., Grelotti D.J., Gupta A., Frank D., Borquez A., p. 1610-1622.
- Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies. Greenwood C.J., Foulds J., McKetin R., Aarsman S.R., Hutchinson D., Kerr J., et al., p. 1623-1633.
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Lodi S., Yan S., Bovell-Ammon B., Christine P.J., Hsu H.E., Bernson D., et al., p. 1634-1645.
- Tusi use among the New York City nightclub-attending population. Palamar J.J., Abukahok N., Acosta P., Krotulski A.J., Walton S.E., Stang B., et al., p. 1646-1654.
- Current and future trends in the consumption, sale and purchasing of alcohol-free and low-alcohol products in Great Britain, 2014 to 2023. Wilson L.B., Stevely A.K., Kersbergen I., McGrane E., Moore E.C., Pryce R.E., et al., p. 1655-1665.
- Examining the longer-term efficacy of brief, alcohol-focused personalized feedback interventions for individuals with internalizing distress: Secondary analysis of a randomized controlled trial. Piccirillo M.L., Graupensperger S., Walukevich-Dienst K., Lehinger E., Smith-LeCavalier K.N., Foster K.T., et al., p. 1666-1678.
- Recommendations for future research exploring e-cigarette use and later cigarette smoking in young people: Results from a consultation exercise. Conde M., Pesko M.F., Shahab L., Begh R., Lindson N., Jackson S.E., et al., p. 1679-1688.
- Rare but relevant: Ketamine-induced cystitis - an in-depth review for addiction medicine. Abdelrahman A., Belal M., p. 1689-1693.
- Oversimplification of a complex public health issue that serves exploitative industry interests. Maddox R., Waa A., Calma T., Whop L.J., p. 1694-1696.
- Response to letter commenting on: Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies? Mendelsohn C.P., Beaglehole R., Borland R., Hall W., Wodak A., Youdan B., et al., p. 1697-1698.